A Phase II Trial of Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with an Anthracycline and Taxane-Reference-Cited by-同舟云学术

A Phase II Trial of Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with an Anthracycline and Taxane

Published:2005-04 Issue:1 Volume:6 Page:55-60
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Modi Shanu,Currie Violante E.,Seidman Andrew D.,Bach Ariadne M.,Panageas Katherine S.,Theodoulou Maria,Moasser Mark M.,D'Andrea Gabriella M.,Lake Diana E.,Choi Jennifer,Norton Larry,Hudis Clifford A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Gemcitabine: preclinical pharmacology and mechanisms of action;Plunkett;Semin Oncol,1996

2. Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer;Possinger;Anticancer Drugs,1999

3. Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial;Blackstein;Oncology,2002

4. Advanced breast cancer: a phase II trial with gemcitabine;Carmichael;J Clin Oncol,1995

5. Single-agent gemcitabine is active in previously treated metastatic breast cancer;Spielmann;Oncology,2001

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerability of eribulin in elderly patients;Medical alphabet;2021-01-23

2. Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data;Journal of Geriatric Oncology;2020-07

3. Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles;Clinical Breast Cancer;2019-04

4. Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study;Oncology;2018

5. Neoplasms of the Breast;Holland‐Frei Cancer Medicine;2017-02-26